Kymera Therapeutics, Inc. (KYMR)

78.14 -1.53 (-1.92%) USD  |  NASDAQ  |  May 19, 16:00
78.14 0.00 (0.00%) Pre-Market: 08:38
More

Kymera Therapeutics Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
AbbVie, Inc. Upgrade